Anant Krishnan

Papers

1

Total Citations

30

H-Index

1

About

Anant Krishnan is a leading figure in the field of interventional oncology, with a focused research interest in the comparative effectiveness and cost-efficiency of minimally invasive treatments for renal cell carcinoma. His work critically evaluates the economic and clinical trade-offs between percutaneous cryoablation and surgical partial nephrectomy for T1a renal tumors. In his landmark 2015 study, Krishnan conducted a rigorous retrospective cost comparison from the hospital perspective, analyzing data from 37 cryoablations against 26 open and 102 robot-assisted partial nephrectomies. This highly cited work (30 citations) provides essential evidence for value-based care, demonstrating that percutaneous cryoablation offers a significant cost advantage while maintaining comparable oncologic outcomes for small renal masses. Krishnan’s contributions are pivotal for clinicians and hospital administrators seeking to optimize resource allocation without compromising patient care. His research continues to shape treatment algorithms, establishing cryoablation as a compelling, cost-effective alternative in the management of localized kidney cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous Cryoablation <i>vs</i> Partial Nephrectomy: Cost Comparison of T1a Tumors
30 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago